Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTheracryf PLC Regulatory News (TCF)

Share Price Information for Theracryf PLC (TCF)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.21
Ask:
0.22
Spread: 0.01 (4.762%)
Market Cap: £4.62m
TCF Live PriceLast checked at - London Stock Exchange

Intraday Theracryf PLC Share Chart

Holding(s) in Company

24 Jun 2026 16:34

RNS Number : 6347J
Theracryf PLC
24 June 2026
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BSVYN304

Issuer Name

THERACRYF PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

First Equity Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

Name

City of registered office

Country of registered office

Estate of William Black

Armstrong Investments Limited

Douglas

Isle of Man

4. Details of the shareholder

Name

City of registered office

Country of registered office

Nortrust Nominees Limited

London

United Kingdom

5. Date on which the threshold was crossed or reached

23-Jun-2026

6. Date on which Issuer notified

24-Jun-2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.013647

0.000000

9.013647

193700000

Position of previous notification (if applicable)

8.082966

0.000000

8.082966

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BSVYN304

193700000

0

9.013647

0.000000

Sub Total 8.A

193700000

9.013647%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Estate of William Black

Armstrong Investments Limited

Estate of William Black

First Equity Limited as Investment Manager of Armstrong Inv Limited

9.013647

9.013647%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

If date does not apply, explain below

 

11. Additional Information

 

12. Date of Completion

24-Jun-2026

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFVERVISFIR
12
Date   Source Headline
7th Mar 202512:04 pmRNSResult of General Meeting
4th Mar 202512:00 pmRNSDirector/PDMR Shareholding
24th Feb 20254:31 pmRNSHolding(s) in Company
19th Feb 202511:04 amRNS£4.25m Placing and Subscription, Notice of GM
19th Feb 202510:54 amRNSAppointment of Dr Alastair Smith as Chair
28th Nov 20247:00 amRNSHalf-year Report
27th Nov 20247:00 amRNS-REuropean Patent Office award decision
15th Nov 202410:58 amRNSHolding(s) in Company
14th Nov 20243:24 pmRNSIssue of Equity and Total Voting Rights
14th Nov 202411:00 amRNSNotice of Results
4th Nov 202411:00 amRNSPassing of Dr Sue Foden, Chair
29th Aug 20247:00 amRNSGrant of Options and PDMR Dealings
8th Aug 202410:23 amRNSHolding(s) in Company
18th Jul 20243:02 pmRNSResult of AGM
17th Jul 202410:26 amRNSHolding(s) in Company
16th Jul 202412:50 pmRNSHolding(s) in Company
10th Jul 20242:00 pmRNS-RPublication of peer-reviewed data on SFX-01
21st Jun 20249:00 amRNSAnnual Financial Report and Notice of AGM
13th Jun 20243:14 pmRNSHolding(s) in Company
13th Jun 20247:00 amRNS-RTheraCryf Research and Development Day
4th Jun 20243:04 pmRNSHolding(s) in Company
28th May 20244:05 pmRNSFinal Results - Correction
28th May 20247:00 amRNSFinal Results
22nd May 20247:00 amRNSNotice of R&D presentation
20th May 20247:00 amRNSNotice of Results
2nd May 202410:47 amRNSHolding(s) in Company
2nd May 20247:00 amRNSChronos Integration Update
2nd May 20247:00 amRNSTotal Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.